Hall Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.25M Buy
2,811
+223
+9% +$263K 0.98% 31
2026
Q2
$3.1M Buy
2,588
+1,346
+108% +$1.38M 0.97% 32
2026
Q1
$1.16M Buy
1,242
+1,024
+470% +$1.04M 0.41% 50
2025
Q4
$234K Buy
+218
New +$208K 0.09% 93

Other funds holding LLY

Hall Capital Management's LLY Position: Q3 2026 in Review

Hall Capital Management increased its Eli Lilly (LLY) stake by 8.6% in Q3 2026, buying an estimated $263K and bringing the position to 2,811 shares worth $3.25M. The position accounts for 0.98% of the portfolio, ranked #31.

Hall Capital Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 3,069 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Hall Capital Management held 2,811 shares of Eli Lilly worth $3.25M as of Q3 2026.
  • Hall Capital Management bought 223 Eli Lilly shares in Q3 2026, an estimated $263K.
  • Eli Lilly made up 0.98% of Hall Capital Management's portfolio in Q3 2026, its #31 holding.
  • Hall Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 3,069 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Hall Capital Management's 13F filing for Q3 2026, filed 9 Nov 2026.